Dr. Reddy's Laboratories Limited
DRREDDY
Rank in Stocks
#1913
Established in 1984 and headquartered in Hyderabad, India, Dr. Reddy's... Established in 1984 and headquartered in Hyderabad, India, Dr. Reddy's Laboratories Limited functions as a fully integrated global pharmaceutical entity. Its business is structured into several core divisions. The Global Generics segment is responsible for the production and distribution of prescription and over-the-counter finished pharmaceutical products, marketed either under their own brand names or as generic versions therapeutically equivalent to branded formulations, also encompassing biologics. The Pharmaceutical Services and Active Ingredients (PSAI) division manufactures and supplies active pharmaceutical ingredients (APIs) and intermediates, which are fundamental components for finished drugs, alongside offering contract research services and custom production of APIs and steroids. The Proprietary Products segment is dedicated to the research and development of unique and differentiated drug formulations. Furthermore, its "Others" segment focuses on developing treatments for oncology and inflammatory conditions. The company's therapeutic reach spans numerous areas including gastro-intestinal, cardiovascular, anti-diabetic, dermatological, oncology, respiratory, stomatological, urological, and nephrological health. Dr. Reddy's also maintains a strategic collaboration with Curis, Inc., centered on the discovery, development, and commercialization of small molecule antagonists for immuno-oncology and precision oncology applications.
Share Price
$13.09
Market Cap
$10.90B
Change (1 day)
-4.33%
Change (1 year)
-10.62%
Country
IN
Trade Dr. Reddy's Laboratories Limited (DRREDDY)
Category
Healthcare
Earnings for Dr. Reddy's Laboratories Limited (DRREDDY)
Earnings in 2026 TTM: 0
According to Dr. Reddy's Laboratories Limited latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Dr. Reddy's Laboratories Limited from 2026 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
